跳至主要内容
临床试验/CTRI/2024/12/078752
CTRI/2024/12/078752尚未招募1 期

A comparative study to evaluate the effectiveness of nebulised dexmedetomidine versus nebulised lignocaine the haemodynamic response to awake fiberoptic intubation in patients of head & neck cancers.

Kalyan Singh Superspeciality Cancer Institute1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月1日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Systolic blood pressure Diastolic blood pressure

研究概览

简要总结

This study aims to compare the effectiveness of nebulised Lignocaine (4 ml of 2% lignocaine) and dexmedetomidine (1µm/kg in 4 ml of normal saline) to blunt the haemodynamic response (as a marker of surface anaesthesia) in patients of head & neck cancers undergoing general anaesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Additional Inclusion Criteria
  • ASA grade 1 and II
  • BMI more than 18kg/m2 and below 29kg/m2
  • Elective surgeries under general anaesthesia
  • Who had given valid informed consent
  • All MP grades including patients with zero mouth opening.

排除标准

  • Patient refusal
  • BMI not between 18kg/m2 29kg/m2
  • Patient allergic to lignocaine or its preservative
  • Emergency surgery and history of laryngeal and pharyngeal surgery.

结局指标

主要结局

Systolic blood pressure Diastolic blood pressure

时间窗: Pre operative period (Before start of nebulisation) | during procedure (Fiberoptic intubation) | then after 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 and 20 minutes.

Heart rate

时间窗: Pre operative period (Before start of nebulisation) | during procedure (Fiberoptic intubation) | then after 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 and 20 minutes.

Mean Arterial Pressure

时间窗: Pre operative period (Before start of nebulisation) | during procedure (Fiberoptic intubation) | then after 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 and 20 minutes.

次要结局

  • side effects associated with the use of these drugs(Pre operative period (Before start of nebulisation))

研究者

发起方
Kalyan Singh Superspeciality Cancer Institute
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Mohd Asim Rasheed

Kalyan Singh Superspeciality Cancer Institute

研究点 (1)

Loading locations...

相似试验